NEP108 is a GID4 E3 ligase-based BRD4 PROTAC degrader, with its DC 50 value approximately 3.8 μM. NEP108 has a strong affinity for GID4, with a K D value of 0.22 μM, and the K D value of its trimeric complex is 2.85 μM. NEP108 can be used for cancer research. (Pink: BRD4 ligand ( HY-78695 ); Blue: Ligands for E3 Ligase ligand ( HY-D2259 ); Black: linker).
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Epigenetic Reader Domain
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.